CIRB Studies
Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
| Study Number | Lead Group | Study Title | CIRB | Study Status |
|---|---|---|---|---|
| NWU2015-06-02 | CLO-Northwestern University | Immunogenicity of Nonavalent HPV Vaccine Administered Prior To Renal Transplantation in Adults: A Prospective, Single-Arm, Multi-Center Clinical Trial | Cancer Prevention and Control CIRB | Available to Open |
| NWU20-01-03 | CLO-Northwestern University | Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD): RELIEF-NAFLD | Cancer Prevention and Control CIRB | Available to Open |
| NWU2014-04-01 | CLO-Northwestern University | Statin Therapy to Reduce the Risk of Recurrent Pancreatitis | Cancer Prevention and Control CIRB | Completed |
| NWU2016-08-02 | CLO-Northwestern University | A Phase I Single-Arm, Multicenter Pilot Study Aimed at Validating Gamma-OHPdG as a Biomarker and Testing the Effects of Polyphenon E® on its Levels in Patients with Cirrhosis | Cancer Prevention and Control CIRB | Available to Open |
| NWU20-02-01 | CLO-Northwestern University | Surgical Window of Opportunity Study of Megestrol Acetate Compared with Megestrol Acetate and Metformin for Endometrial Intraepithelial Neoplasia | Cancer Prevention and Control CIRB | Available to Open |
| NWU2015-06-04 | CLO-Northwestern University | Phase IIB trial of neoadjuvant oral tamoxifen versus transdermal 4-hydroxytamoxifen in women with DCIS of the breast | Cancer Prevention and Control CIRB | Available to Open |
| NWU2015-06-03 | CLO-Northwestern University | Statin Therapy to Reduce Disease Progression from Liver Cirrhosis to Cancer | Cancer Prevention and Control CIRB | Available to Open |
| NWU20-02-02 | CLO-Northwestern University | A Randomized and Placebo-Controlled Phase II Trial Targeting Dominant-Negative Missense Mutant P53 By Atorvastatin for Reducing the Risk of Longstanding Ulcerative Colitis-Associated Cancer | Cancer Prevention and Control CIRB | Available to Open |
| UAZ21-06-01 | CP-CTNet_CLO-University of Arizona | Phase II Randomized, Double Blind, Placebo-Controlled Trial of the Broccoli Seed and Sprout Extract (BSSE), Avmacol ES, to Evaluate Sustained Detoxification of Tobacco Carcinogens in Heavy Smokers | Cancer Prevention and Control CIRB | Available to Open |
| UAZ2015-05-02 | CP-CTNet_CLO-University of Arizona | M4OC-Prevent: Metformin for Oral Cancer Prevention | Cancer Prevention and Control CIRB | Completed |